Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Vreeland
Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Efficacy and Safety of Monotherapy by Pegvisomant, a Growth Hormone Receptor Antagonist, in Japanese Patients With Acromegaly
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Clinical Pharmacokinetics
Pharmacology
Modulation of Growth Hormone Signal Transduction in Kidneys of Streptozotocin-Induced Diabetic Animals: Effect of a Growth Hormone Receptor Antagonist
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer
Clinical Genitourinary Cancer
Oncology
Urology
Antidepressant, Anxiolytic and Anorectic Effects of a Melanin-Concentrating Hormone-1 Receptor Antagonist
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Radiation Therapy and Toll-Like Receptor Signaling: Implications for the Treatment of Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
The Orexin-1 Receptor Antagonist SB-334867 Blocks the Effects of Antipsychotics on the Activity of A9 and A10 Dopamine Neurons: Implications for Antipsychotic Therapy
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Effects of a Growth Hormone-Releasing Hormone Antagonist on Telomerase Activity, Oxidative Stress, Longevity, and Aging in Mice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
